The Babraham Institute, a biotech research unit of Cambridge University, has announced the creation of a new commercialisation vehicle backed by a £44m ($67m) government grant. Babraham Commercialisation Services (BCS) will support the knowledge exchange and commercialisation activities of the institute, already home to around 45 biomedical companies at its research campus. The campus is…
Cambridge’s new venture arm
May 31, 2013 •
LEADERSHIP SOCIETYInforming, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
More featured content
Resistance is futile: seven superconductor companies that want to change the world
From healthcare to fusion to quantum computing to space, superconductors have the potential to revolutionise the world. And the technology is finally ready to commercialise.
UK universities urged to lower spinout stakes
A new report recommends stakes of less than 25% but fails to address the issue of access to early-stage capital.
Feb 7, 2024
Mar 14, 2024
Monterey, CA (USA)
Jun 26, 2024